Ascendis Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
—
Employees—
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
—
Employees—

ASND Key Statistics

Market cap
12.21B
Market cap12.21B
Price-Earnings ratio
-40.58
Price-Earnings ratio-40.58
Dividend yield
—
Dividend yield—
Average volume
397.55K
Average volume397.55K
High today
$205.38
High today$205.38
Low today
$199.57
Low today$199.57
Open price
$202.83
Open price$202.83
Volume
304.08K
Volume304.08K
52 Week high
$216.45
52 Week high$216.45
52 Week low
$118.03
52 Week low$118.03

ASND News

Simply Wall St 5d
Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation Following Expanded SKYTROFA Launch for Adult Growth Hormone Deficiency

Ascendis Pharma (NasdaqGS:ASND) just announced that its SKYTROFA (TransCon hGH) is now broadly available in the United States, with expanded dosing options for...

Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation Following Expanded SKYTROFA Launch for Adult Growth Hormone Deficiency

Analyst ratings

100%

of 16 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.